BKE Rule 144 Notice: 20,000 Shares Planned Sale via UBS on NYSE

Rhea-AI Filing Summary

Form 144 filed for The Buckle, Inc. (BKE) reporting a proposed sale of 20,000 common shares through UBS Financial Services with an approximate aggregate market value of $1,180,000. The filing lists an approximate sale date of 09/05/2025 on the NYSE. The shares were originally acquired on 01/04/2008 as restricted stock units issued as compensation and the filing indicates payment/consideration was compensation-related. The filer reports two recent sales in the past three months: 10,000 shares sold on 07/22/2025 for $497,881 and 10,000 shares sold on 07/23/2025 for $599,324. The notice includes the standard representation that the filer is not aware of undisclosed material adverse information about the issuer.

Positive

• Transparent disclosure of planned sale date, broker, share count, acquisition date, and nature of acquisition (RSU)
• Recent sales reported with specific gross proceeds for investor visibility

Negative

• Insider selling of 20,000 shares (planned) and 20,000 shares sold in July 2025 may be viewed negatively by some investors
• Missing filer relationship to the issuer and absence of a stated 10b5-1 plan adoption date limit context for the sales

Insights

Securities Compliance Analyst

TL;DR: This is a routine Rule 144 notice documenting an insider sale plan and recent dispositions, filed through UBS.

The filing discloses a planned disposition of 20,000 common shares via a broker on the NYSE and documents that the shares were acquired as RSUs in 2008. The form includes two recent dispositions in July 2025 with listed gross proceeds. From a compliance perspective, the form meets Rule 144 notice requirements by identifying acquisition date, nature (compensation RSU), broker, and recent sales. The representation about lack of undisclosed material adverse information is present, which is standard. The filing does not state the filer’s relationship to the issuer, any 10b5-1 plan adoption date, or other contextual detail.

Equity Research Analyst

TL;DR: Insider is selling a modest block of shares; disclosed amounts and dates allow investors to track insider liquidity but not draw conclusions on company performance.

The notice documents sales totaling 20,000 shares planned and 20,000 shares sold in July 2025 with combined gross proceeds of $1,097,205. The planned sale value of $1.18M is explicit. While insider sales can be interpreted by the market, this filing provides transparent transactional data but no commentary on motive or material company developments. Absent additional context (role of filer, size of holding, or plan dates), market impact is likely limited.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
common	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	20000	1180000	51160000	09/05/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
common	01/04/2008	compensation RSU	issuer			20000	01/04/2008	compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
James E Shada 715 E 56th ST. Kearney NE 68847	common	07/22/2025	10000	497881
Jame E Shada 715 E 56th St. Kearney NE 68847	common	07/23/2025	10000	599324

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for The Buckle, Inc. (BKE) disclose?

The Form 144 discloses a proposed sale of 20,000 common shares via UBS on the NYSE with an aggregate market value of $1,180,000 and two prior July 2025 sales of 10,000 shares each.

When were the shares being sold originally acquired?

The shares were acquired on 01/04/2008 as restricted stock units (RSUs) issued as compensation.

Who is the broker handling the proposed sale?

UBS Financial Services Inc., 1000 Harbor Blvd, Weehawken, NJ is listed as the broker.

How much did the recent July 2025 sales generate in gross proceeds?

Two sales generated $497,881 on 07/22/2025 and $599,324 on 07/23/2025, respectively.

Does the filing state any undisclosed material information about the company?

The filer represents they do not know of any material adverse information about the issuer that has not been publicly disclosed.